FileOctopus2.jpg Wikipedia

Octopus UK “megatrial” will test existing drugs as new treatments for MS

4 April 2023 The first patients have been recruited for a revolutionary trial, led by UCL researchers, that will transform the way that treatments are tested for progressive multiple sclerosis (MS). Octopus is a world-first clinical trial, funded by the MS Society and led by researchers at the MRC Clinical Trials Unit at UCL.

Octopus inside the progressive MS megatrial VJNeurology

The Octopus MS clinical trial is the first multi-arm, multi-stage trial for MS. The trial is led by researchers at University College London and is currently testing two drugs already used in other conditions against a placebo (dummy drug). These are metformin and alpha lipoic acid.

Octopuses Get Emotional About Pain, Research Suggests Mind Matters

Octopus is a clinical trial evaluating several potential treatments for primary and secondary progressive multiple sclerosis (MS).

FileOctopus marginatus2.JPG Wikipedia

Octopus is a revolutionary trial that will transform the way we test treatments for progressive MS. A smarter way of testing potential treatments, it could deliver life-changing new treatments up to three times faster.

Octopus Free Stock Photo Public Domain Pictures

Launched in April 2023, Octopus is a revolutionary MS clinical trial that will transform the way we test treatments for progressive MS. The trial is devised to be smarter than the current standard style of clinical trial.

MTR > Tickets and Fares

The Octopus trial is intended to accelerate the search for drugs to treat progressive MS by comparing three against the same control group and rolling trial phases together. The design.

'Major moment in MS research' as new Octopus trial starts Lounge

Inside the MS Octopus mega-trial: inspired by cancer, supported by patients Features Inside the MS mega-trial: inspired by cancer, supported by patients The UK MS Society discusses how it plans to research treatments for progressive MS. Kezia Parkins June 23, 2021

Why we need to find treatments for progressive MS MS Society's Octopus trial YouTube

Octopus is a trial which will test multiple treatments with the aim to find one that can slow down, and ultimately stop, the progression of disability in people with primary or secondary progressive MS. Octopus aims to be a more efficient kind of clinical trial by using the multi-arm, multi-stage (MAMS) approach, visit this page about MAMS for.

FileOctopus vulgaris2.jpg Wikipedia

Monday 14 November 2022 Octopus is a new clinical trial for primary and secondary progressive MS. After some delays, it's now had the official thumbs up from the regulators. This important milestone brings us another step closer to the trial getting started.

FileOctopus vulgaris BCN 0219 Mustekala C.JPG Wikipedia, the free encyclopedia

The Octopus trial - so-called because it is a multi-arm, multi-stage trial - is being run by Prof Jeremy Chataway, from the National Hospital for Neurology and Neurosurgery UCLH in London,.

Octopus photo WP03827

Octopus will test several experimental MS therapies against a shared control group. Treatments that appear effective from early data can continue into the next stage without needing to set up a.

Octopus trial one step closer to launch MS Society

Octopus is a revolutionary trial that will transform the way we test treatments for Progressive Multiple Sclerosis (MS). A smarter way of testing potential treatments, it could deliver life-changing new treatments up to three times faster. Octopus is now open to recruitment!

FileOctopus macropus.jpg Wikipedia

Octopus is the first multi-arm, multi-stage (MAMS) trial for MS. It's designed to transform the way treatments for progressive MS are tested. And it's being led by researchers at University College London. Octopus is currently testing two drugs already used in other conditions. University College London Hospital is currently the only site open.

This octopus learned to use a camera faster than some humans The Independent The Independent

Introducing Octopus - the world's first multi-arm, multi-stage trial for MS Tuesday 4 May 2021 We're pleased to introduce Octopus - our revolutionary, multi-arm, multi-stage trial that will transform the way we test treatments for progressive MS.

Octopus

The Octopus trial is led by Prof Jeremy Chataway at University College London (UCL). Along with the trial site at UCL Queen Square Institute of Neurology, the Anne Rowling Clinic is now open for recruitment. The Octopus trial management team have plans to open 30 Octopus trial sites across the UK. The Anne Rowling Regenerative Neurology Clinic.

Black Octopus MS YouTube

OCTOPUS is the first MS trial to use a type of trial design known as multi-arm multi-stage (MAMS). This method can have many advantages over traditional trials: It allows several treatments to be tested at the same time against a common control (i.e. "multi-arm"). Treatments which appear to be effective from the early data can continue onto.